1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025)
Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market.

By product, the global human microbiome market is classified into probiotics, prebiotics, foods, medical foods, supplements, diagnostic devices, and drugs. The expectation that microbiome products, which will aid in the early-stage treatment of chronic diseases and various disorders, will be available in the market in the future is a key driver for the growth of this market. Other factors such as the rise in aging population, incidence of chronic health problems, and the need to cut healthcare costs will increase the adoption of microbiome-derived products. However, patent applications of microbiome-derived products will require clinical evidence and regulatory approvals; therefore, the promise of significant investment in this segment is uncertain.

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The North American region is expected to register the highest growth rate due to its immense growth opportunities. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as “friendly” bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, the rising incidence of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.


Research Coverage:
The report provides a picture on human microbiome across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, disease, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.


Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall human microbiome market and the subsegments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.


Reasons to buy the report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.


The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the human microbiome market. The report analyzes the human microbiome market by product, application, disease, and region
- Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the human microbiome market
- Market Development: Comprehensive information about the lucrative emerging markets, by product and region
- Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the human microbiome market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the human microbiome market

Table Of Contents

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 24
2.3.3 KEY INDUSTRY INSIGHTS 25
2.3.4 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 HUMAN MICROBIOME : MARKET OVERVIEW 30
4.2 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT (2022) 31
4.3 HUMAN MICROBIOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
4.4 HUMAN MICROBIOME MARKET: GEOGRAPHIC MIX 33
4.5 HUMAN MICROBIOME MARKET: DEVELOPING VS. DEVELOPED REGIONS 33
4.6 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Increased focus on human microbiome therapy 37
5.2.1.2 Human microbiome as new validated target for drug development 37
5.2.1.3 Human microbiome for early disease detection and diagnosis 37

5.2.2 RESTRAINTS 38
5.2.2.1 Lack of expertise and detailed research 38
5.2.2.2 Barriers in proving the causal link between dysbiosis and disease 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Investigational New Drug (IND) requirements for fecal microbiota 38
5.2.3.2 Increasing collaborations create growth opportunities 38
5.2.4 CHALLENGE 39
5.2.4.1 Government regulations 39
5.2.5 BURNING ISSUES 39
5.2.5.1 Abundant opportunities in the human microbiome field and tremendous research investments 39
5.2.5.2 Development of human microbiome therapeutic products 40
5.3 HUMAN MICROBIOME MARKET: PATENTS 41
5.4 HUMAN MICROBIOME MARKET: FUNDING 42
6 HUMAN MICROBIOME MARKET, BY PRODUCT 43
6.1 INTRODUCTION 44
6.2 PROBIOTICS 45
6.3 FOODS 46
6.4 PREBIOTICS 47
6.5 MEDICAL FOODS 48
6.6 DIAGNOSTIC DEVICES 49
6.7 DRUGS 50
6.8 OTHER PROBIOTIC SUPPLEMENTS 51
7 HUMAN MICROBIOME MARKET, BY APPLICATION 52
7.1 INTRODUCTION 53
7.2 THERAPEUTICS 54
7.3 DIAGNOSTICS 55
8 HUMAN MICROBIOME MARKET, BY DISEASE 56
8.1 INTRODUCTION 57
8.2 ACUTE DIARRHEA 58
8.3 OBESITY 59
8.4 DIABETES 60
8.5 AUTOIMMUNE DISORDERS 61
8.6 CANCER 62
8.7 MENTAL DISORDERS 63
8.8 OTHER DISEASES 64

9 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT 65
9.1 INTRODUCTION 66
9.2 INSTRUMENTS 66
9.2.1 LABORATORY INSTRUMENTS 67
9.2.2 ANALYZERS 69
9.3 CONSUMABLES 70
9.3.1 KITS 71
9.3.2 REAGENTS 72
10 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY 74
10.1 INTRODUCTION 75
10.2 CELL CULTURE TECHNOLOGY 75
10.3 HIGH-THROUGHPUT TECHNOLOGY 76
10.4 OMICS TECHNOLOGY 77
10.5 COMPUTATIONAL TOOLS 78
11 HUMAN MICROBIOME MARKET, BY REGION 80
11.1 INTRODUCTION 81
11.2 NORTH AMERICA 83
11.2.1 U.S. 88
11.2.2 CANADA 91
11.3 EUROPE 95
11.4 ASIA-PACIFIC 100
11.5 REST OF THE WORLD (ROW) 104
12 COMPETITIVE LANDSCAPE 107
12.1 OVERVIEW 107
12.2 COMPETITIVE SITUATION AND TRENDS 108
12.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 108
12.2.2 EXPANSIONS 109
12.2.3 PRODUCT LAUNCHES AND APPROVALS 110
12.2.4 OTHER DEVELOPMENTS 111
13 COMPANY PROFILES 112
(Introduction, Products and Services, Strategy, and Analyst Insights, Developments, MnM View)*
13.1 ENTEROME BIOSCIENCE 113
13.2 E.I. DU PONT DE NEMOURS AND COMPANY 115
13.3 MERCK and CO., INC. 119
13.4 METABIOMICS CORPORATION 121
13.5 YAKULT HONSHA CO., LTD. 123
13.6 MICROBIOME THERAPEUTICS, LLC 126
13.7 OSEL, INC. 128
13.8 SECOND GENOME, INC. 129
13.9 VITHERA PHARMACEUTICALS 131
13.10 VEDANTA BIOSCIENCES, INC. 132

*Details on MarketsandMarkets view, Introduction, Product and Services, Strategy, and Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 134
14.1 INSIGHTS FROM INDUSTRY EXPERTS 134
14.2 DISCUSSION GUIDE 135
14.3 OTHER DEVELOPMENTS 138
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 143
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 145
14.6 AVAILABLE CUSTOMIZATIONS 146
14.7 RELATED REPORTS 147
14.8 AUTHOR DETAILS 148


LIST OF TABLES

TABLE 1 HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION) 45
TABLE 2 HUMAN MICROBIOME MARKET SIZE FOR PROBIOTICS, BY REGION,
2022-2025 (USD MILLION) 46
TABLE 3 HUMAN MICROBIOME MARKET FOR FOODS, BY REGION,
2022-2025 (USD MILLION) 47
TABLE 4 HUMAN MICROBIOME MARKET SIZE FOR PREBIOTICS, BY REGION,
2022-2025 (USD MILLION) 48
TABLE 5 HUMAN MICROBIOME MARKET SIZE FOR MEDICAL FOODS, BY REGION,
2022-2025 (USD MILLION) 48
TABLE 6 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC DEVICES,
BY REGION, 2020-2025 (USD MILLION) 49
TABLE 7 HUMAN MICROBIOME MARKET SIZE FOR DRUGS, BY REGION,
2022-2025 (USD MILLION) 50
TABLE 8 HUMAN MICROBIOME MARKET SIZE FOR OTHER PROBIOTIC SUPPLEMENTS,
BY REGION, 2022-2025 (USD MILLION) 51
TABLE 9 HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION) 53
TABLE 10 HUMAN MICROBIOME MARKET SIZE FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2022-2025 (USD MILLION) 54
TABLE 11 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2025 (USD MILLION) 55
TABLE 12 HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION) 58
TABLE 13 HUMAN MICROBIOME MARKET SIZE FOR ACUTE DIARRHEA, BY REGION,
2022-2025 (USD MILLION) 59
TABLE 14 HUMAN MICROBIOME MARKET SIZE FOR OBESITY, BY REGION,
2021-2025 (USD MILLION) 60
TABLE 15 HUMAN MICROBIOME MARKET SIZE FOR DIABETES, BY REGION,
2022-2025 (USD MILLION) 61
TABLE 16 HUMAN MICROBIOME MARKET SIZE FOR AUTOIMMUNE DISORDERS,
BY REGION, 2021-2025 (USD MILLION) 61
TABLE 17 HUMAN MICROBIOME MARKET SIZE FOR CANCER, BY REGION,
2022-2025 (USD MILLION) 62
TABLE 18 HUMAN MICROBIOME MARKET SIZE FOR MENTAL DISORDERS,
BY REGION, 2022-2025 (USD MILLION) 63
TABLE 19 HUMAN MICROBIOME MARKET SIZE FOR OTHER DISEASES,
BY REGION, 2021-2025 (USD MILLION) 64
TABLE 20 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION) 66
TABLE 21 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2014-2021 (USD MILLION) 66
TABLE 22 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,
BY REGION, 2014-2021 (USD MILLION) 67
TABLE 23 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION) 67
TABLE 24 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY REGION, 2014-2021 (USD MILLION) 68
TABLE 25 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION) 68
TABLE 26 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS,
BY REGION, 2014-2021 (USD MILLION) 69
TABLE 27 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY COUNTRY, 2014-2021 (USD MILLION) 69
TABLE 28 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 70
TABLE 29 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY REGION, 2014-2021 (USD MILLION) 70
TABLE 30 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2014-2021 (USD MILLION) 71
TABLE 31 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY REGION, 2014-2021 (USD MILLION) 71
TABLE 32 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY COUNTRY, 2014-2021 (USD MILLION) 72
TABLE 33 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS,
BY REGION, 2014-2021 (USD MILLION) 72
TABLE 34 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY COUNTRY, 2014-2021 (USD MILLION) 73
TABLE 35 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 75
TABLE 36 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION) 75
TABLE 37 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION) 76
TABLE 38 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION) 76
TABLE 39 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION) 77
TABLE 40 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION) 77
TABLE 41 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION) 78
TABLE 42 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY REGION, 2014-2021 (USD MILLION) 78
TABLE 43 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY COUNTRY, 2014-2021 (USD MILLION) 79
TABLE 44 HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022-2025 (USD MILLION) 82
TABLE 45 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 82
TABLE 46 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 85
TABLE 47 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2022-2025 (USD MILLION) 85
TABLE 48 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 86
TABLE 49 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION) 86
TABLE 50 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 87
TABLE 51 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 87
TABLE 52 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2014-2021 (USD MILLION) 87
TABLE 53 U.S.: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 88
TABLE 54 U.S.: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2022-2025 (USD MILLION) 89
TABLE 55 U.S.: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 89
TABLE 56 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 90
TABLE 57 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 90
TABLE 58 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 90
TABLE 59 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 91
TABLE 60 CANADA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 91
TABLE 61 CANADA : HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2022-2025 (USD MILLION) 92
TABLE 62 CANADA : HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 92
TABLE 63 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION) 93
TABLE 64 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 93
TABLE 65 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 94
TABLE 66 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2014-2021 (USD MILLION) 94
TABLE 67 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 95
TABLE 68 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2022-2025 (USD MILLION) 97
TABLE 69 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 97
TABLE 70 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION) 98
TABLE 71 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 98
TABLE 72 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 99
TABLE 73 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2014-2021 (USD MILLION) 99
TABLE 74 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 101
TABLE 75 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2020-2025 (USD MILLION) 101
TABLE 76 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 102
TABLE 77 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION 102
TABLE 78 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 103
TABLE 79 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 103
TABLE 80 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2014-2021 (USD MILLION) 103
TABLE 81 ROW: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,
2022-2025 (USD MILLION) 104
TABLE 82 ROW: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,
2022-2025 (USD MILLION) 104
TABLE 83 ROW: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,
2022-2025 (USD MILLION) 105
TABLE 84 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY PRODUCT, 2014-2021 (USD MILLION) 105
TABLE 85 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION) 106
TABLE 86 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION) 106
TABLE 87 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,
BY TECHNOLOGY, 2014-2021 (USD MILLION) 106
TABLE 88 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016 108
TABLE 89 EXPANSIONS, 2013-2016 109
TABLE 90 PRODUCT LAUNCHES AND APPROVALS, 2013-2016 110
TABLE 91 OTHER DEVELOPMENTS, 2013-2016 111


LIST OF FIGURES

FIGURE 1 HUMAN MICROBIOME: MARKET SEGMENTATION 16
FIGURE 2 HUMAN MICROBIOME RESEARCH SPENDING: MARKET SEGMENTATION 16
FIGURE 3 RESEARCH DESIGN 19
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 21
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 7 PROBIOTICS SEGMENT TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD 26
FIGURE 8 CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE MICROBIOME RESEARCH SPENDING MARKET FROM 2016 TO 2021 27
FIGURE 9 CELL CULTURE TECHNOLOGIES TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015 28
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL HUMAN MICROBIOME MARKET, 2022 29
FIGURE 11 GROWING PREVALENCE OF LIFESTYLE DISEASES AND INCREASING ACCEPTANCE OF MICROBIOME-BASED PRODUCTS ARE MAJOR GROWTH DRIVERS 30
FIGURE 12 PROBIOTICS SEGMENT DOMINATED THE HUMAN MICROBIOME MARKET IN 2022 31
FIGURE 13 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE HUMAN MICROBIOME MARKET IN 2022-2025 32
FIGURE 14 NORTH AMERICA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 15 DEVELOPED REGIONS TO GROW AT HIGHER CAGRS FROM 2022 TO 2025 33
FIGURE 16 CELL CULTURE TECHNOLOGY SEGMENT DOMINATED THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015 34
FIGURE 17 HUMAN MICROBIOME MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 18 FUNDS PROVIDED FOR MICROBIOME RESEARCH BY VARIOUS MEDICAL RESEARCH AGENCIES 40
FIGURE 19 PROBIOTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME PRODUCT MARKET BY 2025 44
FIGURE 20 THE THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME APPLICATIONS MARKET BY 2025 53
FIGURE 21 ACUTE DIARRHEA EXPECTED TO BE THE LARGEST DISEASE SEGMENT OF THE HUMAN MICROBIOME MARKET IN 2022 57
FIGURE 22 GEOGRAPHIC SNAPSHOT (2022): NORTH AMERICA WILL BE THE FASTEST-GROWING REGION BY 2022 81
FIGURE 23 NORTH AMERICA TO GROW AT THE FASTEST RATE IN THE HUMAN MICROBIOME PRODUCT MARKET FROM 2022 TO 2025 84
FIGURE 24 EUROPE: HUMAN MICROBIOME MARKET SNAPSHOT 96
FIGURE 25 COMPANIES ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THE KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 107
FIGURE 26 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS ARE KEY GROWTH STRATEGIES FOR MARKET PLAYERS 108
FIGURE 27 GEOGRAPHIC REVENUE MIX OF TOP 3 MARKET PLAYERS 112
FIGURE 28 E.I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT (2015) 115
FIGURE 29 MERCK and CO., INC.: COMPANY SNAPSHOT (2015) 119
FIGURE 30 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT (2016) 123

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Crohn’s disease (CD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market  Forecast-2023

Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.